著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Gideon M. Hirschfield and Mitchell L. Shiffman and Aliya Gulamhusein and Kris V. Kowdley and John M. Vierling and Cynthia Levy and Andreas E. Kremer and Ehud Zigmond and Pietro Andreone and Stuart C. Gordon and Christopher L. Bowlus and Eric J. Lawitz and Richard J. Aspinall and Daniel S. Pratt and Karina Raikhelson and Maria S. Gonzalez-Huezo and Michael A. Heneghan and Sook-Hyang Jeong and Alma L. Ladrón de Guevara and Marlyn J. Mayo and George N. Dalekos and Joost P.H. Drenth and Ewa Janczewska and Barbara A. Leggett and Frederik Nevens and Victor Vargas and Eli Zuckerman and Christophe Corpechot and Eduardo Fassio and Holger Hinrichsen and Pietro Invernizzi and Palak J. Trivedi and Lisa Forman and David E.J. Jones and Stephen D. Ryder and Mark G. Swain and Alexandra Steinberg and Pol F. Boudes and Yun-Jung Choi and Charles A. McWherter,"Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study",Hepatology,0270-9139,Ovid Technologies (Wolters Kluwer Health),2023-04-06,78,2,397-415,https://cir.nii.ac.jp/crid/1360579816407451904,https://doi.org/10.1097/hep.0000000000000395